Dermatitis, Phototoxic clinical trials
The registry lists 11 studies for Dermatitis, Phototoxic across 5 countries. 0 are recruiting or about to start. 7 of them are mainly about Dermatitis, Phototoxic (how this is decided). Per ClinicalTrials.gov, last updated 2025-03-14.
Status
- Completed
- 10
- Withdrawn
- 1
Who runs them
Medical University of Vienna (1) · MC2 Therapeutics (1) · Pinnacle Biologics Inc. (1) · Herbarium Laboratorio Botanico Ltda (1) · Tibotec Pharmaceuticals, Ireland (1) · Coria Laboratories, Ltd. (1) · PharmaEssentia (1) · Stiefel, a GSK Company (1)
What is being tested here
Drugs under test in Dermatitis, Phototoxic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tirbanibulin | 0 | 0 | 1 |
| Butenafine | 0 | 1 | 1 |
| Simeprevir | 0 | 0 | 1 |
Who these studies take
No Dermatitis, Phototoxic study is recruiting now.
Across all 11 studies, recruiting or not: 55% stop at 75 or younger and 45% at 65; 0% take children; 0% are for women only and 9% for men only; 82% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 11 of 11. search them.
- Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Photosensitization of a Scar GelCompletedNCT06723340Not applicable1 country
- Phototoxicity of Frequently Prescribed MedicinesCompletedNCT06710600Not applicable1 country
- Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male SubjectsCompletedNCT05245578Phase 11 country
- Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human SubjectsCompletedNCT04531527Phase 31 country
- Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 CreamCompletedNCT03892564Phase 11 country
- Prevention of Phototoxicities in Patients Undergoing Vemurafenib TreatmentCompletedNCT03108209Not applicable1 country
- A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy VolunteersCompletedNCT01115322Phase 11 country
- Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible LightWithdrawnNCT01256203Phase 2
- Clinical Evaluation of the Phototoxic Potential of Xenaderm OintmentCompletedNCT00644917Phase 1
- TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun LightCompletedNCT01124799Phase 1
- Clinical Evaluation of the Photoallergy Potential of Atralin GelCompletedNCT00603772Phase 11 country